心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 CSI立场声明：心衰的管理

2018-07-20 印度心脏病学学会 Indian Heart J. 2018 Jul;70 Suppl 1:S1-S72.

心衰管理

2018年7月，印度心脏病学学会(CSI)发布了关于印度心衰管理的立场声明，全球范围内约有2600心衰患者，该类患者的管理给国家卫生保健资源带来了巨大的压力，本文主要为印度心衰的管理声明，涉及心衰的流行病学，评估，管理，预防等。

中文标题：

2018 CSI立场声明：心衰的管理

英文标题：

CSI position statement on management of heart failure in India

发布机构：

印度心脏病学学会

发布日期：

2018-07-20

简要介绍：

2018年7月，印度心脏病学学会(CSI)发布了关于印度心衰管理的立场声明，全球范围内约有2600心衰患者，该类患者的管理给国家卫生保健资源带来了巨大的压力，本文主要为印度心衰的管理声明，涉及心衰的流行病学，评估，管理，预防等。 

拓展指南：与心衰相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 CSI立场声明：心衰的管理)] GetToolGuiderByIdResponse(projectId=1, id=014121c001631124, title=2018 CSI立场声明：心衰的管理, enTitle=CSI position statement on management of heart failure in India, guiderFrom=Indian Heart J. 2018 Jul;70 Suppl 1:S1-S72., authorId=null, author=, summary=2018年7月，印度心脏病学学会(CSI)发布了关于印度心衰管理的立场声明，全球范围内约有2600心衰患者，该类患者的管理给国家卫生保健资源带来了巨大的压力，本文主要为印度心衰的管理声明，涉及心衰的流行病学，评估，管理，预防等。 , cover=, journalId=null, articlesId=null, associationId=1695, associationName=印度心脏病学学会, associationIntro=, copyright=0, guiderPublishedTime=Fri Jul 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年7月，印度心脏病学学会(CSI)发布了关于印度心衰管理的立场声明，全球范围内约有2600心衰患者，该类患者的管理给国家卫生保健资源带来了巨大的压力，本文主要为印度心衰的管理声明，涉及心衰的流行病学，评估，管理，预防等。 </div> <div><br> </div>拓展指南：<strong>与<font color="red">心衰</font>相关指南：</strong><br><ul><li><a title="2018年美国心脏协会《右心衰竭的评估和管理》声明解读" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=ff7c81c001629aa6">2018年美国心脏协会《右心衰竭的评估和管理》声明解读</a></li> <li><a title="2018 营养和饮食学会循证实践指南：心衰患者的管理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=b6d8b1c00159324b">2018 营养和饮食学会循证实践指南：心衰患者的管理</a></li> <li><a title="2018 AHA科学声明：右心衰的评估和管理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=f124c1c001580e21">2018 AHA科学声明：右心衰的评估和管理</a></li> <li><a title="2018 HFA/ESC立场声明：2型糖尿病和心衰" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=a82c61c00156e0c7">2018 HFA/ESC立场声明：2型糖尿病和心衰</a></li> <li><a title="《生物标志物在心衰预防、评估以及管理中的作用》解读" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=13a191c0015ae861">《生物标志物在心衰预防、评估以及管理中的作用》解读</a></li> 更多信息请点击：<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%A1%B0">有关心衰更多指南</a></ul>, tagList=[TagDto(tagId=448, tagName=心衰), TagDto(tagId=4059, tagName=管理)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6435, appHits=540, showAppHits=0, pcHits=4697, showPcHits=1550, likes=106, shares=12, comments=13, approvalStatus=1, publishedTime=Fri Aug 24 23:23:46 CST 2018, publishedTimeString=2018-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 24 23:23:46 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:18:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 CSI立场声明：心衰的管理)])
2018 CSI立场声明：心衰的管理
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=349634, encodeId=9b72349634b5, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0c72226271, createdName=lxjy2008_74690166, createdTime=Wed Oct 17 10:11:13 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341083, encodeId=8fcb34108357, content=学习了解，感谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/02/328c4971762e29538e4842286ddd170b.jpg, createdBy=36742075189, createdName=首丘, createdTime=Mon Aug 27 10:51:16 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341074, encodeId=2c543410e43f, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:42:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341073, encodeId=6da43410e3ed, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:55 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341072, encodeId=60173410e29b, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:50 CST 2018, time=2018-08-27, status=1, ipAttribution=)]
    2018-10-17 lxjy2008_74690166

    学习中

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=349634, encodeId=9b72349634b5, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0c72226271, createdName=lxjy2008_74690166, createdTime=Wed Oct 17 10:11:13 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341083, encodeId=8fcb34108357, content=学习了解，感谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/02/328c4971762e29538e4842286ddd170b.jpg, createdBy=36742075189, createdName=首丘, createdTime=Mon Aug 27 10:51:16 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341074, encodeId=2c543410e43f, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:42:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341073, encodeId=6da43410e3ed, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:55 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341072, encodeId=60173410e29b, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:50 CST 2018, time=2018-08-27, status=1, ipAttribution=)]
    2018-08-27 首丘

    学习了解，感谢！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=349634, encodeId=9b72349634b5, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0c72226271, createdName=lxjy2008_74690166, createdTime=Wed Oct 17 10:11:13 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341083, encodeId=8fcb34108357, content=学习了解，感谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/02/328c4971762e29538e4842286ddd170b.jpg, createdBy=36742075189, createdName=首丘, createdTime=Mon Aug 27 10:51:16 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341074, encodeId=2c543410e43f, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:42:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341073, encodeId=6da43410e3ed, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:55 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341072, encodeId=60173410e29b, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:50 CST 2018, time=2018-08-27, status=1, ipAttribution=)]
    2018-08-27 xiaotao112411

    学习学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=349634, encodeId=9b72349634b5, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0c72226271, createdName=lxjy2008_74690166, createdTime=Wed Oct 17 10:11:13 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341083, encodeId=8fcb34108357, content=学习了解，感谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/02/328c4971762e29538e4842286ddd170b.jpg, createdBy=36742075189, createdName=首丘, createdTime=Mon Aug 27 10:51:16 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341074, encodeId=2c543410e43f, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:42:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341073, encodeId=6da43410e3ed, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:55 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341072, encodeId=60173410e29b, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:50 CST 2018, time=2018-08-27, status=1, ipAttribution=)]
    2018-08-27 xiaotao112411

    学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=349634, encodeId=9b72349634b5, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0c72226271, createdName=lxjy2008_74690166, createdTime=Wed Oct 17 10:11:13 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341083, encodeId=8fcb34108357, content=学习了解，感谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/02/328c4971762e29538e4842286ddd170b.jpg, createdBy=36742075189, createdName=首丘, createdTime=Mon Aug 27 10:51:16 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341074, encodeId=2c543410e43f, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:42:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341073, encodeId=6da43410e3ed, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:55 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341072, encodeId=60173410e29b, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Mon Aug 27 08:41:50 CST 2018, time=2018-08-27, status=1, ipAttribution=)]
    2018-08-27 xiaotao112411

    学习学习学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2018 营养和饮食学会循证实践指南：心衰患者的管理

美国营养与饮食学会(Academy of Nutrition and Dietetics) · 2018-05-11

2018 HFA/ESC立场声明：2型糖尿病和心衰

欧洲心力衰竭协会(HFA,Heart Failure Association) · 2018-03-08

《生物标志物在心衰预防、评估以及管理中的作用》解读

暂未更新 · 2017-12-30

2017 EPCCS实践指南：基层医疗中心衰的诊断和管理

欧洲心血管初级保健学会(EPCCS,European Primary Care Cardiovascular Society) · 2017-12-10

2017 AHA科学声明：生物标志物在心衰预防，评估以及管理中的作用

美国心脏协会(AHA,American Heart Association) · 2017-04-26

心力衰竭的春天因你来，最新心力衰竭指南集锦！

暂未更新 · 2017-03-28